Matrix Metalloproteinase Inhibition Protects Hepatic Integrity in Hemorrhagic Shock

Journal of Gastrointestinal Surgery

Volumn 4, Issue 5, 2000, Pages 536-541

  Santibanez Gallerani, A S ^a   Barber, A E ^a   Williams, S J ^a   Davis, S ^a   Zhao, Y ^a   Shires, G T ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Hemorrhage; Liver; Shock

Indexed keywords

INTERLEUKIN 6; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL MEMBRANE POTENTIAL; DISEASE MODEL; DRUG ANTAGONISM; HEMORRHAGIC SHOCK; HUMAN; LIVER; MALE; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-6; LIVER; MALE; MATRIX METALLOPROTEINASES; MEMBRANE POTENTIALS; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034264091     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(00)80098-0     Document Type: Article

References (44)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
2. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s: Systemic inflammatory response and organ dysfunction. JAMA 1994;271:226-233.
3. Baue AE. Multiple organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome: Where do we stand? Shock 1994;2:385-397.
4. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A. The APACHE III prognosis system: Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100;1619-1636.
5. Deitch EA. Gut-liver axis in multiple system organ failure: Role of bacterial translocation and endotoxemia. In Matuschak GM, ed. Multiple Systems Organ Failure: Hepatic Regulation of Systemic Host Defense. New York: Marcel Dekker, 1993, p 39.
6. Matuschak GM. Liver-lung interactions in critical illness. New Horizons 1994;2:488-504.
7. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in the liver allografts. An overview and synthesis of current studies. Transplantation 1992;53:957-978.
8. Hasselgren PO. Prevention and treatment of ischemia of the liver. Surg Gynecol Obstet 1987;164:187-196.
9. Hsueh W, Sun X, Rioja LN, Gonzalez-Crussi F. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin. Immunology 1990; 70:309-314.
10. Komatsu H, Koo A, Ghadishah E, Zeng H, Kuhlenkamp JF, Inoue M, Guth PH, Kaplowitz N. Neutrophil accumulation in ischemic reperfused rat liver: Evidence for the role for superoxide free radicals. Am J Physiol 1992;262:G669-G676.
11. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990;4:3355-3359.
12. Marubayashi S, Dohi K, Ochi K, Kawasaki T. Role of free radicals in ischemic rat liver cell injury: Prevention of damage by g-tocopherol administration. Surgery 1986;99:184-192.
13. Atalla SL, Toledo-Pereyra LH, MacKenzie GH, Cederna JP. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 1985;40:584-590.
14. Metzger J, Dore SP, Lauterburg BH. Oxidant stress during reperfusion of ischemic liver: No evidence for a role of xanthine oxidase. Hepatology 1988;8:580-584.
15. Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K. Processing of tumor necrosis factor-α precursor by metalloproteinase. Nature 1994;370:555-557.
16. Bradham CA, Plumpe J, Manns MP, Brenner DA, Trautwein C. Mechanisms of hepatic toxicity in TNF-induced liver injury. Am J Physiol 1998;275(3 Pt 1):G387-G392.
17. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Strieter RM. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1996;23:506-514.
18. 2. J Surg Res 1998;80:136-142.
19. Bahrami S, Yao YM, Leichtfried G, Redl H, Marzi I, Schlag G. Significance of TNF in hemorrhage-related hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol 1997;272:H2219-H2226.
20. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Strieter RM. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. J Clin Invest 1995;95:134-141.
21. McGeehan GM, Becherer JD, Bast RC, Boyer CM, Champion B, Connolly KM, Conway JG, Furdon P, Karp S, Kidao S, McElroy AB, Nichols J, Pryzwansky KM, Schoenen F, Sekut L, Truesdale A, Verghese M, Warner J, Ways JP. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 1994;370:558-561.
22. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements JM, Crimmin M, Davidson AH, Drummond AH, Galloway WA, Gilbert R. Matrix metalloproteinases and processing of pro-TNF-alpha. J Leukocyte Biol 1995;57:774-777.
23. Shiono S, Fantini GA, Roberts JP, Chiao J, Shires GT. Assessment of the early cellular membrane response to live Escherichia coli bacteremia. J Surg Res 1989;46:9-15.
24. Trunkey DD, Illner H, Wagner IY, Shires GT. The effect of hemorrhagic shock on the intracellular muscle action potentials in the primate. Surgery 1973;74:241-250.
25. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985;202: 685-693.
26. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock: Relation to multiple organ failure and mortality. Chest 1993;103: 565-575.
27. Goris RJ, Boekhorst TP, Nuytinck JK, Gimbrere JS. Multiple organ failure: Generalized autodestructive inflammation? Arch Surg 1985;120:1109-1115.
28. Roumen RM, Redl H, Schlag G, Slow G, Sandtner W, Koller W, Hendriks T, Goris RJ. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995;23:474-480.
29. Cerra FB, Siegel JH, Coleman B, Border JR, McMenamy RR. Septic auto-cannibalism: A failure of exogenous nutritional support. Ann Surg 1980;192:570-580.
30. Cerra FB. Hypermetabolism-organ failure syndrome: A metabolic response to injury. Crit Care Clin 1989;5:289-302.
31. Barber AE, Jones WG, Minei JP, Fahey TJ, Lowry SF, Shires GT. Bacterial overgrowth and intestinal atrophy in the etiology of gut barrier failure in the rat. Am J Surg 1991;161:300-304.
32. Ayala A, Perrin MM, Meldrum DR, Ertel W, Chaudry IH. Hemorrhage induces an increase in serum TNF-α which is not associated with elevated levels of endotoxin. Cytokines 1990;2:170-174.
33. Tamion F, Richard V, Lyoumi S, DaveauM, Bonmarchand G, Leroy J, Thuillez C, Lebreton JP. Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am J Physiol 1997;273:G314-G321.
34. Goris RJ, Boekholtz WK, van Bebber IP, Nuytinck JK, Schillings PH. Multiple organ failure and sepsis without bacteria. An experimental model. Arch Surg 1986;121:897-901.
35. Andus T, Holstege A. Cytokines and the liver in health and disease. Effects on liver metabolism and fibrogenesis. Acta Gastroenterol Belg 1994;57:236-244.
36. Murakami K, Kobayashi F, Ikegawa R, Koyama M, Shintani N, Yoshida T, Nakamura N, Kondo T. Metalloproteinase inhibitor prevents hepatic injury in endotoxemic mice. Eur J Pharmacol 1998;341:105-110.
37. Chang TW. Improvement of survival from hemorrhagic shock by enterectomy in rats: Finding to implicate the role of the gut for irreversibility of hemorrhagic shock. J Trauma 1997;42:223-230.
38. Peitzman AB, Corbett WA, Shires GT III, Illner H, Shires GT, Inamdar R. Cellular function in liver and muscle during hemorrhagic shock in primates. J Clin Surg 1982;5:315-322.
39. Shires GT, Cunningham JN, Backer CR, Reeder SF, Illner H, Wagner IY, Maher J. Alterations in cellular membrane function during hemorrhagic shock in primates. Ann Surg 1972; 176:288-295.
40. Holliday RL, Illner HP, Shires GT. Liver cell membrane alterations during hemorrhagic shock in rat. J Surg Res 1981;31: 506-515.
41. Amundson B, Haljamae H. Skeletal muscle metabolites as possible indicators of imminent death in acute hemorrhage. Eur Surg Res 1976;8:311-320.
42. Amundson B, Jennische E, Haljamae H, Correlative analysis of microcirculatory and cellular metabolic events in skeletal muscle during hemorrhagic shock. Acta Physiol Scand 1980; 108:147-158.
43. Benedict CR, Grahame-Smith DG. Plasma noradrenaline and adrenaline concentrations and dopamine-B-hydroxylase activity in patients with shock due to septicemia, trauma, and hemorrhage. Q J Med 1978;185:1-20.
44. Oyama T, Matsuki A, Kudo M, Yamashita M, Ishihara H. Effect of corticosteroids on endocrine function in haemorrhagic shock. Canad Anaesth Soc J 1978;25:7-17.